Health
GW team to play a role in Sanofi COVID-19 vaccine clinical trial – News-Medical.Net
The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites…
The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a phase 2 study for its adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Our research team at GW is proud to play a role in testing COVID-19 vaccine candidates to help end one of the greatest public health challenges of our time. We know that in order to end this pandemic, we’ll need more than…
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News13 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal